ANESTHESO
ActiveANESTHESO has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €765k and a net result of €215k. Equity is growing by ~19.8% per year across the filed fiscal years. Its solvency ranks better than 77% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98▲+1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €70k at 30 days acceptable
Liquidity ample (current ratio 6.9 against 5.7 in 2024; short-term debt: 13.9% and cash: 12.2% of total assets), and 13.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
86.1%
Return on assets
24.2%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 08-12-2025, 54 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
54 d early
2024
43 d early
2023
on the day
2022
on the day
2021
42 d early
2020
27 d early
2019
1 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close19-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€0
2022 · €0
2019: €0
2020: €0
2022: €0
2019 → 2023
Total assets
€889k▲ 15.3%
2024 · €771k
2019: €280k
2020: €328k
2021: €384k
2022: €610k
2023: €637k
2024: €771k
2019 → 2025
Net result
€215k▲ 22.9%
2024 · €175k
2019: €127k
2020: €118k
2021: €92k
2022: €165k
2023: €147k
2024: €175k
2019 → 2025
Working capital
€731k▲ 23.4%
2024 · €592k
2019: €177k
2020: €272k
2021: €363k
2022: €412k
2023: €489k
2024: €592k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€0€0
Equity€369k-€476k▲ 29.0%€560k▲ 17.8%€645k▲ 15.1%€765k▲ 18.6%
Operating result€128k-€233k▲ 82.2%€208k▼ 10.9%€255k▲ 23.0%€244k▼ 4.6%
Net result€92k-€165k▲ 79.7%€147k▼ 10.9%€175k▲ 18.9%€215k▲ 22.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €889k
Fixed assets
€34k▼ 34.6%
Current assets
€855k▲ 19.0%
Equity and liabilities €889k
Equity
€765k▲ 18.6%
Debt
€124k▼ 1.7%
The debt ratio falls from 16.4% to 13.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€264k▼
2024 · €276k
Cash flow
€235k▲
2024 · €195k
Solvency
86.1%▲
2024 · 83.6%
Current ratio
6.90▲
2024 · 5.70
Quick ratio
6.90▲
2024 · 5.70
Debt / equity
0.16▼
2024 · 0.20
ROE
28.1%▲
2024 · 27.1%
ROA
24.2%▲
2024 · 22.7%
Interest coverage
5.84▼
2024 · 329.59
Debt
€124k▼
2024 · €126k
Debt ≤ 1 year
€124k▼
2024 · €126k
Income taxes
€96k▲
2024 · €86k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€771k€889k▲
Formation expenses20€0€0=
Fixed assets21/28€53k€34k▼
Tangible fixed assets22/27€52k€34k▼
Furniture and vehicles24€49k€31k▼
Other tangible fixed assets26€3k€3k▼
Financial fixed assets28€198€160▼
Current assets29/58€719k€855k▲
Amounts receivable within one year40/41€121k€103k▼
Trade receivables40€121k€101k▼
Other amounts receivable41€0€2k▲
Current investments50/53€491k€641k▲
Cash at bank and in hand54/58€105k€108k▲
Deferred charges and accrued income490/1€2k€3k▲
Equity and liabilities
Total equity and liabilities10/49€771k€889k▲
Equity10/15€645k€765k▲
Contributions10/11€1k€1k=
Outside capital11-€1k
Other1109/19-€1k
Reserves13€644k€764k▲
Distributable reserves133€644k€764k▲
Amounts payable17/49€126k€124k▼
Amounts payable within one year42/48€126k€124k▼
Current portion of amounts payable after more than one year42€0-
Financial debts43€3k€0▼
Credit institutions430/8€3k€0▼
Trade debts44€2k€5k▲
Suppliers440/4€2k€5k▲
Taxes, remuneration and social security45€31k€23k▼
Taxes450/3€31k€23k▼
Remuneration and social security454/9€0€0=
Other amounts payable47/48€90k€96k▲
Accrued charges and deferred income492/3-€0
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21k€20k▼
Other operating charges640/8€384€387▲
Gross operating margin9900€276k€264k▼
Operating profit (loss)9901€255k€244k▼
Financial income75/76B€6k€113k▲
Recurring financial income75€6k€113k▲
Financial charges65/66B€872€45k▲
Recurring financial charges65€837€45k▲
Non-recurring financial charges66B€35€38▲
Profit (loss) for the period before taxes9903€260k€311k▲
Income taxes67/77€86k€96k▲
Profit (loss) for the period9904€175k€215k▲
Profit (loss) for the period to be appropriated9905€175k€215k▲
Appropriation of the result
Profit (loss) to be appropriated9906€175k€215k▲
Transfer from equity791/2€90k€95k▲
Transfer to equity691/2€175k€215k▲
To other reserves6921€175k€215k▲
Profit to be distributed694/7€90k€95k▲
Return on contributions (dividend)694€90k€95k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
08-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial
Highest result since 2019net €215k ▲22.9%
Net result €215k, the highest in the series.
2024
19-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Equity above €500kEq €560k ▲17.8%
5 profitable years in a row build equity to €560k.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
20-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
30-06
Financial
Weakest financial yearnet €92k ▼22.3%
Net result drops to €92k, the lowest in the series; recovery starts the following year.
30-06
Financial
Liquidity quadruplescurrent ratio 24.85
Current ratio from 6.45 to 24.85; short-term debt falls from €50k to €15k.
04-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Liquidity doublescurrent ratio 6.45
Current ratio from 2.99 to 6.45; short-term debt falls from €89k to €50k.
30-06
Financial
Equity above €200kEq €278k ▲50.4%
2 profitable years in a row build equity to €278k.
30-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
23-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
30-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
16-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wezembeek-Oppem · 1 establishment unit since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hertogenlaan 1131970 Wezembeek-OppemGround area
789 m²
Building footprint
129 m²
Volume, LiDAR
874 m³
Parcel 22302D0329/00N000, Flanders · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Hertogenlaan 113, 1970 Wezembeek-Oppem
since 20092.180.557.228
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22302D0329/00N000 | Flanders | 789 m² | 1 · 128 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. CUYKX
BE 0864.309.491
Wommelgem · Eq €772k
RM CHIRURGIE PLASTIQUE
BE 0711.818.464
Wemmel · Eq €754k
Clinic 12B
BE 0845.535.142
Antwerpen · Eq €795k
CECILIA BRAMBILLA
BE 0810.705.412
Vorst · Eq €813k
DOKTER VANTIEGHEM GREET
BE 0807.205.888
Torhout · Eq €819k
Of 105 companies in sector 86109 we hold annual accounts for 83. 62 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-05-2006
Fiscal year end30-06
Activities, NACEBEL
86109Human health activities
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.